Evidence map›Paper›PMID 28729267›Full record

ArticleGenome announcements2017

Draft Genome Sequence of the

Robert F Potter, Alaric W D'Souza, Meghan A Wallace, Angela Shupe, Sanket Patel, Danish Gul, Jennie H Kwon, Saadia Andleeb, C A Burnham, Gautam Dantas

Abstract read
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Multidrug-resistantIDCases · 2026
    Article
  2. Polyphasic discrimination ofApplied and environmental microbiology · 2025
    Article
  3. Article
  4. Occurrence and Characterization of NDM-1-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  5. Biochemical and biophysical characterization of the OXA-48-like carbapenemase OXA-436.Acta crystallographica. Section F, Structural biology communications · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robert F PotterCenter for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
Alaric W D'SouzaCenter for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
Meghan A WallaceDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Angela ShupeDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Sanket PatelDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Danish GulAtta ur Rahman School of Applied Biosciences, National University of Sciences and Technology Islamabad, Islamabad, Pakistan.
Jennie H KwonDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Saadia AndleebAtta ur Rahman School of Applied Biosciences, National University of Sciences and Technology Islamabad, Islamabad, Pakistan.
C A BurnhamDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA cburnham@wustl.edu dantas@wustl.edu.
Gautam DantasCenter for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA cburnham@wustl.edu dantas@wustl.edu.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
ESTABLISHMENT AND DYNAMICS OF ANTIBIOTIC RESISTANCE RESERVOIRS IN DEVELOPING INTER01GM099538 · NIGMS · WASHINGTON UNIVERSITY · PI DANTAS, GAUTAM · 2013 to 2016
$1.2M
NCATS NIH HHS KL2 TR000450NCATS NIH HHS KL2 TR002346NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCEZID CDC HHS U54 CK000609NIGMS NIH HHS R01 GM099538NIGMS NIH HHS T32 GM007067NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

We sequenced a carbapenem-resistant

Identifiers

PMID28729267
PMCPMC5522934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.